Abstract
Viral infections remain major causes of human morbidity and mortality, and therapy of ongoing infection remains in most cases elusive. Prophylaxis, however, has been dramatically effective; vaccination has eradicated smallpox and has diminished the incidence of the more severe viral infections (mumps, rubella, measles, and polio) at least in the “developed” countries. Nevertheless, in “underdeveloped” countries these diseases, and the consequent morbidity and mortality, remain problematic. For example, measles virus infections in the Third World lead directly (via viral encephalitis or giant-cell pneumonia) or indirectly (via bacterial superinfection) to an estimated 1–2 million deaths per year. Furthermore, since the appearance of HIV the contribution of viruses to human suffering has escalated greatly, and this will only increase. The search for an HIV vaccine drives much of the current effort to dissect the antiviral immune response molecularly.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andrew ME, Coupar BE (1988) Efficacy of influenza haemagglutinin and nucleoprotein as protective antigens against influenza virus infection in mice. Scand J Immunol 28:81–85
Bachmann MF, Kundig TM, Freer G, Li Y, Kang CY, Bishop DH, Hengartner H, Zinkernagel RM (1994) Induction of protective cytotoxic T cells with viral proteins. Eur J Immunol 24:2228–2236
Cox GJM, Zamb TJ, Babiuk LA (1993) Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. J Virol 67:5664–5667
Del Val M, Schlicht HJ, Volkmer H, Messerle M, Reddehase MJ, Koszinowski UH (1991) Protection against lethal cytomegalovirus infection by a recombinant vaccine containing a single nonameric T-cell epitope. J Virol 65:3641–3646
Enria DA, Fernandez NJ, Briggiler AM, Levis SC, Maiztegui JI (1984) Importance of dose of neutralizing antibodies in treatment of argentine hemorrhagic fever with immune plasma. Lancet 2:255–256
Fulginiti VA, Eller JJ, Downie AW, Kempe CH (1967) Atypical measles in children previously immunized with inactivated measles virus vaccine. JAMA 202:1075–1080
Furth PA, Hennighausen L, Baker C, Beatty B, Woychick R (1991) The variability in activity of the universally expressed human cytomegalovirus immediate early gene 1 enhancer/promoter in transgenic mice. Nucleic Acids Res 19:6205–6208
Fynan EF, Robinson HL, Webster RG (1993) Use of DNA encoding influenza hemagglutinin as an avian influenza vaccine. DNA Cell Biol 12:785–789
Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL (1993) DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci USA 90:11478–11482
Gilkeson GS, Grudier JP, Karounos DG, Pisetsky DS (1989) Induction of antidouble stranded DNA antibodies in normal mice by immunization with bacterial DNA. J Immunol 142: 1482–1486
Good RA (1991) Experiments of nature in the development of modern immunology. Immunol Today 12:283–286
Good RA, Zak SJ (1956) Disturbance in gamma-globulin synthesis as “experiments of nature”. Pediatrics 18:109–149
Gray MM, Hann IM, Glass S, Eden OB, Jones PM, Stevens RF (1987) Mortality and morbidity caused by measles in children with malignant disease attending four major treatment centres: a retrospective review. Br Med J 295:19–22
Hany M, Oehen S, Schulz M, Hengartner H, Mackett M, Bishop DHL, Overton H, Zinkernagel RM (1989) Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein. Eur J Immunol 19:417–424
Jonjic S, del Val M, Keil GM, Reddehase MJ, Koszinowski UH (1988) A nonstructural viral protein expressed by a recombinant vaccinia virus protects against lethal cytomegalovirus infection. J Virol 62:1653–1658
Kapikian AZ, Mitchell RH, Chanock RM, Shvedoff RA, Stewart CE (1969) An epidemiologic study of altered clinical reactivity to respiratory syncitial (RS) virus infection in children previously vaccinated with an inactivated RS vaccine. Am J Epidemiol 89:404–421
Klavinskis LS, Whitton JL, Oldstone MBA (1989) Molecularly engineered vaccine which expresses an immunodominant T-cell epitope induces cytotoxic T lymphocytes that confer protection from lethal virus infection. J Virol 63: 4311–4316
Klavinskis LS, Whitton JL, Joly E, Oldstone MBA (1990) Vaccination and protection from a lethal viral infection: identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope. Virology 178:393–400
Koedood M, Fichtel A, Meier P, Mitchell PJ (1995) Human cytomegalovirus (HCMV) immediate-early enhancer/promoter specificity during embryogenesis defines target tissues of congenital HCMV infection. J Virol 69:2194–2207
Koszinowski UH, Reddehase MJ, Jonjic S (1991) The role of CD4 and CD8 T cells in viral infections. Curr Opin Immunol 3:471–475
Kuwano K, Tamura M, Ennis FA (1990) Cross-reactive protection against influenza A virus infections by an NS1-specific CTL clone. Virology 178:174–179
Lausch RN, Staats H, Metcalf JF, Oakes JE (1990) Effective antibody therapy in herpes simplex virus ocular infection. Characterization of recipient immune response. Intervirology 31:159–165
Lin FT, Chen SB, Wang YZ, Sun CZ, Zeng FZ, Wang GF (1988) Use of serum and vaccine in combination for prophylaxis following exposure to rabies. Rev Infect Dis 10 Suppl 4: S766–S770
Lin H, Parmacek MS, Morle G, Bolling S, Leiden JM (1990) Expression of recombinant genes in myocardium in vivo after direct injection of DNA. Circulation 82:2217–2221
McKinney REJ, Katz SL, Wilfert CM (1987) Chronic enteroviral meningoencephalitis in agammaglobulinemie patients. Rev Infect Dis 9:334–356
Misbah SA, Spickett GP, Ryba PC, Hockaday JM, Kroll JS, Sherwood C, Kurtz JB, Moxon ER, Chapel HM (1992) Chronic enteroviral meningoencephalitis in a gammaglobulinemia: case report and literature review. J Clin Immunol 12: 266–270
Murphy BR, Sotnikov AV, Lawrence LA, Banks SM, Prince GA (1990) Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3–6 months after immunization. Vaccine 8:497–502
Nahmias AJ, Griffith D, Salsbury C, Yoshida K (1967) Thymic aplasia with lymphopenia, plasma cells, and normal immunoglobulins. Relation to measles virus infection. JAMA 201:729–734
Oldstone MBA, Tishon A, Geckeler R, Lewicki H, Whitton JL (1992) A common antiviral cytotoxic T-lymphocyte epitope for diverse major histocompatibility complex haplotypes: implications for vaccination. Proc Natl Acad Sci USA 89:2752–2755
Pedroza Martins L, Lau LL, Asano MS, Ahmed R (1995) DNA vaccination against persistent viral infection. J Virol 69:2574–2582
Raz E, Carson DA, Parker SE, Parr TB, Abai AM, Aichinger G, Gromkowski SH, Singh M, Lew D, Yankauckas MA (1994) Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc Natl Acad Sci USA 91:9519–9523
Robinson HL, Hunt LA, Webster RG (1993) Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine 11:957–960
Schulz M, Aichele P, Vollenweider M, Bobe FW, Cardinaux F, Hengartner H, Zinkernagel RM (1989) Major histocompatibility complex-dependent T cell epitopes of lymphocytic choriomeningitis virus nucleoprotein and their protective capacity against viral disease. Eur J Immunol 19:1657–1668
Schulz M, Zinkernagel RM, Hengartner H (1991) Peptide-induced antiviral protection by cytotoxic T cells. Proc Natl Acad Sci USA 88:991–993
Sedegah M, Hedstrom R, Hobart P, Hoffman SL (1994) Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc Natl Acad Sci USA 91:9866–9870
Siegel MM, Walter TK, Ablin AR (1977) Measles pneumonia in childhood leukemia. Pediatrics 60:38–40
Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Feigner PL, Dwarki VJ, Gromkowski SH, Deck RR, DeWitt CM, Friedman A et al. (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745–1749
Vahlsing HL, Yankauckas MA, Sawdey M, Gromkowski SH, Manthorpe M (1994) Immunization with plasmid DNA using a pneumatic gun. J Immunol Methods 175:11–22
Weidt G, Utermohlen O, Zerrahn J, Reimann J, Deppert W, Lehmann-Grube F (1994) CD8 + T lymphocyte-mediated antiviral immunity in mice as a result of injection of recombinant viral proteins. J Immunol 153:2554–2561
Weidt G, Deppert W, Buchhop S, Dralle H, Lehmann-Grube F (1995) Antiviral protective immunity induced by MHC complex class I molecule-restricted viral T lymphocyte epitopes inserted in various positions in immunologically self and non-self proteins. J Virol 69:2654–2658
Whitton JL (1994) The use of minigenes in antiviral vaccination. In: Talwar GP, Rao KVS, Chauhan VS (eds) Recombinant and synthetic vaccines. Narosa, New Delhi, pp 429–438
Whitton JL (1994) Induction of protective immunity using minigenes. In: Ades EW, Rest RF, Morse SA (eds) Microbial pathogenesis and immune response. New York Academy of Sciences, New York, pp 107–117
Whitton JL, Southern PJ, Oldstone MBA (1988) Analyses of the cytotoxic T lymphocyte responses to glycoprotein and nucleoprotein components of lymphocytic choriomeningitis virus. Virology 162:321–327
Whitton JL, Tishon A, Lewicki H, Gebhard JR, Cook T, Salvato MS, Joly E, Oldstone MBA (1989) Molecular analyses of a five-amino-acid cytotoxic T-lymphocyte (CTL) epitope: an immunodominant region which induces nonreciprocal CTL cross-reactivity. J Virol 63:4303–4310
Whitton JL, Sheng N, Oldstone MBA, McKee TA (1993) A “string-of-beads” vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge. J Virol 67:348–352
Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Feigner PL (1990) Direct gene transfer into mouse muscle in vivo. Science 247:1465–1468
Xiang ZQ, Spitalnik S, Tran M, Wunner WH, Cheng J, Ertl HC (1994) Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199:132–140
Yokoyama M, Zhang J, Whitton JL (1995) DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection. J Virol 69: 2684–2688
Zhu N, Liggitt D, Liu Y, Debs R (1993) Systemic gene expression after intravenous DNA delivery into adult mice. Science 261:209–211
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Verlag Berlin Heidelberg
About this paper
Cite this paper
Whitton, J.L., Yokoyama, M., Zhang, J. (1996). DNA Immunization in an Arenavirus Model. In: Eibl, M.M., Huber, C., Peter, H.H., Wahn, U. (eds) Symposium in Immunology V. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79896-2_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-79896-2_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-60061-9
Online ISBN: 978-3-642-79896-2
eBook Packages: Springer Book Archive